#None #Precision Medicine #Community Oncology #Xtalks

Upcoming Webinar: Improving Precision Medicine in Community Oncology Care

In the realm of oncology, there exists a significant gap between traditional academic models and the realities of community-based care. Most prevalent cancer treatment strategies are typically crafted and assessed within the walls of prominent academic centers. However, the majority of patients find themselves receiving care in community oncology practices, where timelines for biopsy, tissue adequacy, turnaround times on molecular results, payer management, and various social determinants of health heavily influence the efficacy and consistency of precision medicine delivery.

To address these gaps and enhance patient care, Xtalks, in collaboration with Amplity, is hosting a free webinar on June 4, 2026. This session aims to empower healthcare practitioners and life sciences professionals with a comprehensive understanding of how to effectively utilize a community oncology test-to-treat playbook for improving biomarker testing, clinical interventions, and evidence-building at scale.

Who Will Be Speaking?
The event will feature a panel of distinguished national experts in oncology, including:

• - Kashyap Patel, MD - CEO of Carolina Blood and Cancer Care Associates
• - Debra Patt, MD, PhD, MBA - Executive Vice President of Policy and Strategy at Texas Oncology
• - Susan Duffy - President of Comms, Amplity
• - Kristin Siyahian - VP of Branded Channels, Amplity

Each speaker will break down the integral roles that various real-world elements, such as payer requirements and referral networks, play in the community's adoption of precision oncology and how these components differ markedly from academic center operations.

Key Discussion Topics

The webinar will cover vital subjects including:

• - The implications of broader germline testing for diverse community populations, particularly when critical findings arise outside established guideline criteria.
• - How social determinants of health can measurably impact outcomes for underserved cohorts undergoing genomic tests.
• - The criteria involved in making decisions about liquid biopsy implementation.
• - Strategies to gather evidence across various patient demographics.
• - Methods for scaling access and ensuring proper use of new therapies and diagnostic tools.

Using real case studies and insights from published community data, the session will showcase how local practices can implement the fundamental principles of precision medicine. This will ultimately assist leaders in life sciences in employing clinically relevant insights to develop and deliver more effective oncology therapeutics, diagnostics, and evidence strategies.

How to Register

Don't miss this opportunity to transform community oncology practices and improve patient outcomes. To register for the webinar, please visit Xtalks Events.

About Xtalks:
Xtalks operates as a leading life science community, empowering professionals across pharmaceuticals, biotech, medtech, healthcare, and research sectors. It stands firm in providing trusted insights and collaborative knowledge that are instrumental in advancing the industry forward. By leveraging webinars, articles, podcasts, and expert perspectives, Xtalks amplifies informed decision-making in a rapidly changing environment. Thousands of professionals each year count on Xtalks for timely information and inspiration.

Learn more about Xtalks at www.xtalks.com or check out partnership options.

For additional inquiries regarding this event, contact Vera Kovacevic at +1 (416) 977-6555 x371 or via email at [email protected].

Join us in paving the way towards enhanced timely and effective cancer care in community settings.